-+ 0.00%
-+ 0.00%
-+ 0.00%

MAPLIGHT THERAPEUTICS INC - IRIS TRIAL RESULTS EXPECTED IN Q3 2026

Reuters·01/09/2026 12:00:01

Please log in to view news